Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

PTP1B shows promise for the improvement of islet graft revascularization

Oct. 8, 2015

Yissum reports mushroom ostreolyisin compositions

Oct. 6, 2015

New approaches for the treatment of diabetes: ECM capsules and bioactive nanocoatings

Oct. 6, 2015

EMA accepts Ultragenyx's MAA for aceneuramic acid prolonged release

Oct. 5, 2015

Pfizer introduces DGAT-2 inhibitors

Oct. 5, 2015

FDA awards orphan drug designation to RGX-111 for MPS I

Oct. 5, 2015

BioMarin to acquire global rights to Kuvan and pegvaliase from Merck Serono

Oct. 1, 2015

Takeda submits NDA for fixed-dose combination of Nesina and metformin in Japan

Sep. 30, 2015

Bcl-2-like protein 11 is directly involved in beta cell apoptosis

Sep. 30, 2015

Novo Nordisk discloses results from second phase IIIa trial of semaglutide in type 2 diabetes

Sep. 29, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...